Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) are the most mature treatment of immunotherapy and have changed the mode of cancer treatment. Recent studies showed that combining ICIs with targeted drugs is a potential strategy in some tumors, while in other tumors, this combination increases to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bin, Jin, Juan, Guo, Duancheng, Tao, Zhonghua, Hu, Xichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216018/
https://www.ncbi.nlm.nih.gov/pubmed/37345194
http://dx.doi.org/10.3390/cancers15102858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216018/
https://www.ncbi.nlm.nih.gov/pubmed/37345194
http://dx.doi.org/10.3390/cancers15102858

Ejemplares similares